A China-linked advanced persistent threat actor tracked as UAT-9244 has been targeting telecommunication service providers in South America since 2024, compromising Windows, Linux, and network-edge ...
NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with multiple sclerosis. NICE has said Biogen's Tysabri can now be used by the NHS ...